Movement Alert｜Hinge Health, Inc. Intraday Rise 5.08% in Regular Trading, analysts raised targets after stronger-than-expected quarterly results

Market Focus11-04

On November 4, Hinge Health, Inc. rose 5.08% in Regular Trading, trading at $123.15/share, with turnover of $58.54 million.

The move followed a fresh analyst target increase after the company posted better-than-expected quarterly results and lifted its full-year revenue outlook.

Recent coverage showed RBC raised its price target to $135 from $110 while maintaining an Outperform rating. That followed Hinge Health, Inc. reporting third-quarter adjusted earnings of $0.71 per diluted share on revenue of $235 million, both above analyst expectations, while fourth-quarter revenue guidance of $249 million to $251 million also topped consensus.

The company additionally raised full-year revenue guidance to $879 million to $881 million, above its prior outlook of $856 million to $860 million and ahead of the $860.6 million analyst estimate, reinforcing the positive earnings-driven backdrop behind the stock’s advance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment